West, N., Hemmings, G., Richman, S., Taylor, M., Chambers, P., Magill, L., . . . Quirke, P. (2012). KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial.
芝加哥风格引文West, N., et al. KRAS and BRAF Mutational Status Can Be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT Trial. 2012.
MLA引文West, N., et al. KRAS and BRAF Mutational Status Can Be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT Trial. 2012.